Controlled Trial Evaluating Avacopan in C3 Glomerulopathy

NCT03301467 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

C3 Glomerulopathy (C3G)

Interventions

DRUG: Avacopan
DRUG: Avacopan Matching Placebo

Sponsor

Amgen

Collaborators

[object Object]